Literature DB >> 21805161

Knowledge levels of pharmaceutical sales representatives in pain therapy: a descriptive questionnaire-based study.

Christoph L Lassen1, Kirstin Fragemann, Tobias Klier, Nicole Meyer, Bernhard M Graf, Christoph H R Wiese.   

Abstract

PURPOSE: Pain is a common physiological reaction. The development and sale of medication against pain is a main focus of pharmaceutical companies, with total sales of prescription analgesics amounting to US$50 billion in 2009. In this market, advertising is necessary. One way to market both new and old drugs is through direct physician-to-pharmaceutical sales representative (PSR) contact. PSRs see themselves ideally as equal partners to the physicians they advise, thereby setting high standards for themselves. In this setting, PSRs should therefore have an adequate knowledge of pain therapy. The aim of this study was to evaluate whether these standards can be met by PSRs working in the area of pain medicine in terms of their level of education and knowledge of pain topics.
METHODS: We distributed 114 questionnaires that were divided into demographic and knowledge sections. Of these, 90 questionnaires (79%) were returned completed. Since there is no complete list of PSRs working in pain medicine in Germany, we could not draw a representative sample for our study.
RESULTS: We collected general demographic data on PSRs as well as on their educational backgrounds. Analysis of the completed questionnaires revealed that there was a high requirement for PSRs to acquire further education in pain therapy. In the knowledge section, PSRs were asked to rate a total of 70 statements on pain therapy as to whether they were true or false. The mean total of correctly rated statements was 48 (69%).
CONCLUSIONS: Based on the results, we conclude that most PSRs do not meet their ideal high standards of being equal partners to the specialist physicians they visit. More education is needed to achieve this goal.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805161     DOI: 10.1007/s00228-011-1103-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

1.  A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.

Authors:  Klaus Lieb; Simone Brandtönies
Journal:  Dtsch Arztebl Int       Date:  2010-06-04       Impact factor: 5.594

2.  A survey of cancer pain management knowledge and attitudes of British Columbian physicians.

Authors:  R Gallagher; P Hawley; W Yeomans
Journal:  Pain Res Manag       Date:  2004       Impact factor: 3.037

Review 3.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

4.  Interactions of doctors with the pharmaceutical industry.

Authors:  M A Morgan; J Dana; G Loewenstein; S Zinberg; J Schulkin
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

5.  A survey of Chinese nurses' current knowledge of pain in older people.

Authors:  Hui-Dan Yu; Marcia A Petrini
Journal:  J Clin Nurs       Date:  2007-05       Impact factor: 3.036

6.  Knowledge of attitudes to opioids in palliative care patients.

Authors:  Katherine Lambert; Stephen Oxberry; Charles W Hulme; Kirsten Saharia; Alan S Rigby; Miriam J Johnson
Journal:  Palliat Med       Date:  2007-12       Impact factor: 4.762

7.  Nurse prescribers' interactions with and perceptions of pharmaceutical sales representatives.

Authors:  Kevin A Clauson; Nile M Khanfar; Hyla H Polen; Florencetta Gibson
Journal:  J Clin Nurs       Date:  2009-01       Impact factor: 3.036

8.  [Cancer pain therapy in palliative care patients: knowledge of prehospital emergency physicians in training. Prospective questionnaire-based investigation].

Authors:  C H R Wiese; E K Löffler; J Vormelker; N Meyer; M Taghavi; M Strumpf; S Kazmaier; M Roessler; Y A Zausig; A F Popov; C L Lassen; B M Graf; G G Hanekop
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

9.  Medical students' exposure to and attitudes about drug company interactions: a national survey.

Authors:  Frederick S Sierles; Amy C Brodkey; Lynn M Cleary; Frederick A McCurdy; Matthew Mintz; Julia Frank; D Joanne Lynn; Jason Chao; Bruce Z Morgenstern; William Shore; John L Woodard
Journal:  JAMA       Date:  2005-09-07       Impact factor: 56.272

10.  The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians.

Authors:  Sander D Borgsteede; Christiaan A Rhodius; Peter A G M De Smet; H Roeline W Pasman; Bregje D Onwuteaka-Philipsen; Mette L Rurup
Journal:  Eur J Clin Pharmacol       Date:  2010-09-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.